 European experience bone-marrow transplantation severe immunodeficiency outcome bone-marrow transplantations BMT March patients severe immunodeficiency SCID Recipients HLA-identical BMTs probability survival median follow-up months median follow-up months good prognosis rapid development cell function HLA-non-identical T-cell-depleted BMT survival median follow-up months Factors poor prognosis presence lung infection BMT absence protected environment use female donors male recipients Use conditioning regimen frequency sustained engraftment vs non-conditioned BMT frequent engraftment donor myeloid cells Donor B-cell chimerism development normal B-cell function